Editor’s Note: This paper was updated on June 27, 2025 to reflect changes made to #WeCount’s data limitations section in its most recently released report. This is Issue 34 of the American Reports Series. Appendix A (Table 1), Appendix B (Tables 2-7), Appendix C (Table 8), and Appendix D (Table 9), referenced throughout this paper, […]| Lozier Institute
Reproductive rights advocates breathed a sigh of relief on Thursday after the U.S. Supreme Court dismissed a lawsuit attempting to restrict access to the abortion pill mifepristone and telehealth abortion nationwide.'While the Supreme Court did the bare minimum today, we know anti-abortion extremists aren’t stopping any time soon.”The fall 2024 elections are critical to maintaining abortion pills access. The president appoints the head of the FDA, who controls the status of mifepristone. ...| Ms. Magazine
Since Roe was overturned, thousands of people in red states have found a way to get an abortion—often thanks to providers operating at the edge of the law.| The Nation
On March 26, the Supreme Court heard oral arguments in FDA v. Alliance for Hippocratic Medicine, a lawsuit attempting to remove the abortion pill mifepristone from the U.S. market. Mifepristone is now used in approximately two-thirds of abortions in the U.S. While members of the Supreme Court appeared likely to dismiss the case, abortion opponents are working on several other fronts to achieve their goal of banning abortion pills nationwide or restricting access by eliminating telemedicine ab...| Ms. Magazine
Two years after the US Supreme Court revoked the constitutional right to abortion, an increasingly robust body of evidence is emerging that illustrates the myriad harms caused and exacerbated by the Dobbs v. Jackson Women’s Health Organization decision. Several dozen peer-reviewed studies and other rigorous research conducted since June 2022 illustrate key facets of the impact of Dobbs, including data on changes in clinic numbers, abortion incidence and travel for abortion care. This empiri...| Guttmacher Institute
New Guttmacher Institute research from the Monthly Abortion Provision Study shows that there were approximately 642,700 medication abortions in the United States in 2023, accounting for 63% of all abortions in the formal health care system. This is an increase from 2020, when medication abortions accounted for 53% of all abortions. | Guttmacher Institute
Use of medication abortion in the formal US health care system has risen substantially from 53% of all abortions in 2020 to 63% in 2023. In the first full calendar year following the US Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision, approximately 642,700 medication abortions took place within the health care system, according to new data from the Guttmacher Institute’s Monthly Abortion Provision Study. | Guttmacher Institute
